444 related articles for article (PubMed ID: 27612857)
1. Neurochemical evidence supporting dopamine D1-D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation.
Rico AJ; Dopeso-Reyes IG; Martínez-Pinilla E; Sucunza D; Pignataro D; Roda E; Marín-Ramos D; Labandeira-García JL; George SR; Franco R; Lanciego JL
Brain Struct Funct; 2017 May; 222(4):1767-1784. PubMed ID: 27612857
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
[TBL] [Abstract][Full Text] [Related]
3. Expression of GPR55 and either cannabinoid CB
Martínez-Pinilla E; Rico AJ; Rivas-Santisteban R; Lillo J; Roda E; Navarro G; Lanciego JL; Franco R
Brain Struct Funct; 2020 Sep; 225(7):2153-2164. PubMed ID: 32691218
[TBL] [Abstract][Full Text] [Related]
4. Differential localization of mRNAs encoding dopamine D1 or D2 receptors in cholinergic neurons in the core and shell of the rat nucleus accumbens.
Jongen-Rêlo AL; Docter GJ; Jonker AJ; Voorn P
Brain Res Mol Brain Res; 1995 Jan; 28(1):169-74. PubMed ID: 7707872
[TBL] [Abstract][Full Text] [Related]
5. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
Aubert I; Ghorayeb I; Normand E; Bloch B
J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
[TBL] [Abstract][Full Text] [Related]
6. L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus.
Bonaventura J; Rico AJ; Moreno E; Sierra S; Sánchez M; Luquin N; Farré D; Müller CE; Martínez-Pinilla E; Cortés A; Mallol J; Armentero MT; Pinna A; Canela EI; Lluís C; McCormick PJ; Lanciego JL; Casadó V; Franco R
Neuropharmacology; 2014 Apr; 79():90-100. PubMed ID: 24230991
[TBL] [Abstract][Full Text] [Related]
7. Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia.
Farré D; Muñoz A; Moreno E; Reyes-Resina I; Canet-Pons J; Dopeso-Reyes IG; Rico AJ; Lluís C; Mallol J; Navarro G; Canela EI; Cortés A; Labandeira-García JL; Casadó V; Lanciego JL; Franco R
Mol Neurobiol; 2015 Dec; 52(3):1408-1420. PubMed ID: 25344317
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism.
Graham WC; Sambrook MA; Crossman AR
Brain Res; 1993 Feb; 602(2):290-303. PubMed ID: 8095431
[TBL] [Abstract][Full Text] [Related]
9. The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia.
Perreault ML; Hasbi A; Alijaniaram M; Fan T; Varghese G; Fletcher PJ; Seeman P; O'Dowd BF; George SR
J Biol Chem; 2010 Nov; 285(47):36625-34. PubMed ID: 20864528
[TBL] [Abstract][Full Text] [Related]
10. D1 and D2 dopamine receptors in perinatal and adult basal ganglia.
Boyson SJ; Adams CE
Pediatr Res; 1997 Jun; 41(6):822-31. PubMed ID: 9167195
[TBL] [Abstract][Full Text] [Related]
11. Effects of hippocampal kainic acid lesions on striatolimbic dopamine D1-, D2-, and D4-like receptors.
Tarazi FI; Campbell A; Baldessarini RJ
Neuroscience; 1998 Nov; 87(1):1-4. PubMed ID: 9722137
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.
Fauchey V; Jaber M; Caron MG; Bloch B; Le Moine C
Eur J Neurosci; 2000 Jan; 12(1):19-26. PubMed ID: 10651856
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous distribution of dopamine D1 and D2 receptors in the human ventral striatum.
Berendse HW; Richfield EK
Neurosci Lett; 1993 Feb; 150(1):75-9. PubMed ID: 8097026
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958.
Grondin R; Goulet M; Morissette M; Bédard PJ; Di Paolo T
Eur J Pharmacol; 1999 Aug; 378(3):259-63. PubMed ID: 10493101
[TBL] [Abstract][Full Text] [Related]
15. Evidence against dopamine D1/D2 receptor heteromers.
Frederick AL; Yano H; Trifilieff P; Vishwasrao HD; Biezonski D; Mészáros J; Urizar E; Sibley DR; Kellendonk C; Sonntag KC; Graham DL; Colbran RJ; Stanwood GD; Javitch JA
Mol Psychiatry; 2015 Nov; 20(11):1373-85. PubMed ID: 25560761
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
Morin N; Jourdain VA; Morissette M; Grégoire L; Di Paolo T
Neuropharmacology; 2014 Apr; 79():688-706. PubMed ID: 24456747
[TBL] [Abstract][Full Text] [Related]
17. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
Morissette M; Goulet M; Calon F; Falardeau P; Blanchet PJ; Bédard PJ; Di Paolo T
Mol Pharmacol; 1996 Nov; 50(5):1073-9. PubMed ID: 8913337
[TBL] [Abstract][Full Text] [Related]
18. Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys.
Herrero MT; Augood SJ; Asensi H; Hirsch EC; Agid Y; Obeso JA; Emson PC
Brain Res Mol Brain Res; 1996 Nov; 42(1):149-55. PubMed ID: 8915594
[TBL] [Abstract][Full Text] [Related]
19. Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users.
Okita K; Morales AM; Dean AC; Johnson MC; Lu V; Farahi J; Mandelkern MA; London ED
Mol Psychiatry; 2018 May; 23(5):1320-1327. PubMed ID: 28894300
[TBL] [Abstract][Full Text] [Related]
20. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
Frohna PA; Rothblat DS; Joyce JN; Schneider JS
Synapse; 1995 Jan; 19(1):46-55. PubMed ID: 7709343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
